Scott, MT, et al. (2016) Epigenetic Reprogramming Sensitizes CML Stem Cells to Combined EZH2 and Tyrosine Kinase Inhibition. Cancer Discov. 2016 Nov 1; 6(11):1248-1257. PM ID: 27630125